If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Franco Morelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Induction Chemotherapy Medicine & Life Sciences
Germ Cell and Embryonal Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2020

Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors

Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Jan 2020, In : Cancers. 12, 1, 84.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Survival
Disease-Free Survival
Hemoglobins
Multivariate Analysis

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S. & De Giorgi, U., Mar 19 2019, In : Future Oncology. p. 1115-1123 8 p.

Research output: Contribution to journalArticle

Castration
Cyclophosphamide
Prostatic Neoplasms
Safety
docetaxel

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S. & Giorgi, U. D., 2019, In : Future Oncology. 15, 10, p. 1115-1123 9 p.

Research output: Contribution to journalArticle

Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs

Calvani, N., Morelli, F., Naglieri, E., Gnoni, A., Chiuri, V. E., Orlando, L., Fedele, P. & Cinieri, S., Sep 1 2019, In : Medical Oncology. 36, 9, 80.

Research output: Contribution to journalArticle

Taxoids
Castration
Cyclophosphamide
Prostatic Neoplasms
Adrenal Cortex Hormones

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Dec 30 2019, In : Cancers. 12, 1

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Survival
Disease-Free Survival
Hemoglobins
Multivariate Analysis